In the last trading session, 1.1 million Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) shares changed hands as the company’s beta touched -0.08. With the company’s per share price at $5.40 changed hands at -$0.34 or -5.92% during last session, the market valuation stood at $1.36B. MRVI’s last price was a discount, traded about -114.07% off its 52-week high of $11.56. The share price had its 52-week low at $4.28, which suggests the last value was 20.74% up since then. When we look at Maravai LifeSciences Holdings Inc’s average trading volume, we note the 10-day average is 1.89 million shares, with the 3-month average coming to 1.84 million.

Analysts gave the Maravai LifeSciences Holdings Inc (MRVI) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.93. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended MRVI as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight. Maravai LifeSciences Holdings Inc’s EPS for the current quarter is expected to be -0.04.

Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) trade information

Instantly MRVI was in red as seen at the end of in last trading. With action 2.08%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -17.56%, with the 5-day performance at 2.08% in the green. However, in the 30-day time frame, Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) is -27.61% down. Looking at the short shares, we see there were 6.96 million shares sold at short interest cover period of 3.1 days.

The consensus price target for the stock as assigned by Wall Street analysts is 22, meaning bulls need an upside of 75.45% from its current market value. According to analyst projections, MRVI’s forecast low is 10 with 25 as the target high. To hit the forecast high, the stock’s price needs a -362.96% plunge from its current level, while the stock would need to soar -85.19% for it to hit the projected low.

Maravai LifeSciences Holdings Inc (MRVI) estimates and forecasts

Data shows that the Maravai LifeSciences Holdings Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -37.93% over the past 6 months, a -366.67% in annual growth rate that is considerably lower than the industry average of 11.00%. Year-over-year growth is forecast to reach -9.83% down from the last financial year.

Consensus estimates given by 13 financial analysts project the company’s revenue in the current quarter to hit an average of 56.64M. 10 analysts are of the opinion that Maravai LifeSciences Holdings Inc’s revenue for the current quarter will be 64.82M. The company’s revenue for the corresponding quarters a year ago was 74.14M and 64.18M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -23.60%. The estimates for the next quarter sales put growth at 0.99%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -37.53%. The 2024 estimates are for Maravai LifeSciences Holdings Inc earnings to decrease by -370.82%, but the outlook for the next 5-year period is at 2.77% per year.

MRVI Dividends

Maravai LifeSciences Holdings Inc is expected to release its next quarterly earnings report in January.

Maravai LifeSciences Holdings Inc (NASDAQ:MRVI)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 1.37% of Maravai LifeSciences Holdings Inc shares while 102.81% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 104.24%. There are 102.81% institutions holding the Maravai LifeSciences Holdings Inc stock share, with GTCR LLC the top institutional holder. As of 2024-06-30, the company held 15.2267% of the shares, roughly 20.15 million MRVI shares worth $144.27 million.

12 WEST CAPITAL MANAGEMENT LP holds the second largest percentage of outstanding shares, with 9.9833% or 13.21 million shares worth $94.59 million as of 2024-06-30.